Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children

Pediatric Nephrology

Volumn 25, Issue 5, 2010, Pages 919-925

  Topaloglu, Rezan ^a   Er, Ilkay ^a   Dogan, Bahar Guciz ^a   Bilginer, Yelda ^a   Ozaltin, Fatih ^a   Besbas, Nesrin ^a   Ozen, Seza ^a   Bakkaloglu, Aysin ^a   Gur, Deniz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Children; Community acquired infection; Extended spectrum beta lactamases (ESBL) producing bacteria; Risk factors; Urinary tract infection

Indexed keywords

BACTERIAL ENZYME; EXTENDED SPECTRUM BETA LACTAMASE;

ADOLESCENT; ARTICLE; BACTERIUM ISOLATE; CHILD; CHILD HEALTH; COMMUNICABLE DISEASE; CONTROLLED STUDY; DISEASE COURSE; DRUG EXPOSURE; DRUG USE; ESCHERICHIA COLI; FEMALE; HOSPITALIZATION; HUMAN; INFANT; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SYMPTOM; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; ESCHERICHIA COLI; FEMALE; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT, NEWBORN; KLEBSIELLA; LOGISTIC MODELS; MALE; ODDS RATIO; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TURKEY; URINARY TRACT INFECTIONS;

EID: 77951257524     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-009-1431-3     Document Type: Article

References (31)

1. PA Bradford 2001 Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat Clin Microbiol Rev 14 933 951 10.1128/CMR.14.4.933-951.2001 1:CAS:528:DC%2BD3MXot1Wms7Y%3D 11585791 (Pubitemid 32979636)
2. DM Livermore 2003 Bacterial resistance origins, epidemiology and impact Clin Infect Dis 36 Suppl 1 S11 S23 10.1086/344654 1:CAS:528:DC%2BD3sXht1ynu74%3D 12516026 (Pubitemid 36140465)
3. A Philippon G Arlet PH Lagrange 1994 Origin and impact of plasmid mediated extended-spectrum beta-lactamases Eur J Clin Microbiol Infect Dis 13 Suppl 1 17 29 10.1007/BF02390681 (Pubitemid 24287897)
4. DD Pitout KB Laupland 2008 Extended-spectrum β-lactamase producing Enterobacteriaceae: an emerging public health concern Lancet 8 159 166 10.1016/S1473-3099(08)70041-0 1:CAS:528:DC%2BD1cXjsl2gsbg%3D (Pubitemid 351249250)
5. D Gür TL Pitt LMC Hall HE AkalIn DM Livermore 1992 Diversity of klebsiellae with extended-spectrum beta-lactamases at a Turkish University Hospital J Hosp Infect 22 163 166 10.1016/0195-6701(92)90101-Q 1358959
6. KS Meyer C Urban JA Eagan BJ Berger 1993 Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins Ann Intern Med 119 353 358 1:STN:280:DyaK3szjt1eisA%3D%3D 8135915 (Pubitemid 23310083)
7. L Naumovski JP Quinn D Miyashiro PK Bush SB Singer D Graves T Palzkill AM Arvin 1992 Outbreak of ceftazidime resistance due to a novel extended-spectrum -lactamase in isolates from cancer patients Antimicrob Agents Chemother 36 1991 1996 1:CAS:528:DyaK38Xmt12qtb4%3D 1416892
8. DA Schiappa MK Hayden MG Matushek F Hashemi J Sulvian KY Smith D Miyashiro JP Quinn RA Weinstein GM Trenholme 1996 Ceftazidime- resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation J Infect Dis 174 529 536 1:STN:280:DyaK28zmsFCgsQ%3D%3D 8769610 (Pubitemid 26299686)
9. DL Paterson WC Ko A Von Gottberg JM Casellas L Mulazimoglu KP Klugman RA Bonomo LB Rice JG McCormack VL Yu 2001 Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum -lactamases: implications for the clinical microbiology laboratory J Clin Microbiol 39 2206 2212 10.1128/JCM.39.6.2206-2212.2001 1:CAS:528:DC%2BD3MXkslCksLw%3D 11376058 (Pubitemid 32531482)
10. DL Paterson WC Ko AV Gottberg S Mohapatra JM Casellas H Goossens L Mülazimoglu G Trenholme KP Klugman RA Bonomo LB Rice MM Wagener JG McCormack VL Yu 2004 Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum -lactamases Clin Infect Dis 39 31 37 10.1086/420816 1:CAS:528:DC%2BD2cXmtlSgtr4%3D 15206050 (Pubitemid 38879546)
11. YK Kim H Pai HJ Lee SE Park EH Choi J Kim JH Kim EC Kim 2002 Bloodstream infections by extended-spectrum -lactamase producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome Antimicrob Agents Chemother 46 1481 1491 10.1128/AAC.46.5.1481-1491.2002 1:CAS:528:DC%2BD38XjtFKkt7g%3D 11959586 (Pubitemid 34415332)
12. TE Zaoutis MG Goyal JH Chu SE Coffin LM Bell I Nachamkin KL McGowan WB Bilker E Lautenbach 2009 Risk factors and outcomes of bloodstream infection caused by extended-spectrum -lactamase-producing Escherichia coli and Klebsiella species in children Pediatrics 115 942 949 10.1542/peds.2004-1289
13. Hibberd PL, Jacoby GA (1994) Multiple drug resistant Klebsiella pneumoniae (MDRKP) strains: predictors of acquisition and mortality [abstract no C46]. In: Program and abstracts of the 34th Interscience Conference Antimicrobial Agents and Chemotherapy (Orlando, FL). American Society for Microbiology, Washington, DC, p 87
14. R Colodner W Rock B Chazan N Keller N Guy W Sakran R Raz 2004 Risk factors for the development of extended-spectrum -lactamase-producing bacteria in nonhospitalized patients Eur J Clin Microbiol Infect Dis 23 163 167 10.1007/s10096-003-1084-2 1:STN:280:DC%2BD2c7ltFentA%3D%3D 14986159 (Pubitemid 38471420)
15. E Calbo V Romani M Xercavins L Gomez CG Vidal S Quintana J Vila J Garau 2006 Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum -lactamases J Antimicrob Chemother 57 780 783 10.1093/jac/dkl035 1:CAS:528:DC%2BD28Xis1Glur0%3D 16492721
16. KC Kuo YH Shen KP Hwang 2007 Clinical implications and risk factors of extended-spectrum beta-lactamase producing Klebsiella pneumoniae infection in children: a case-control retrospective study in a medical center in southern Taiwan J Microbiol Immunol Infect 40 248 254 17639166
17. Polhamus B, Dalenius K, Thompson D, Scanlon K, Borland E, Smith B, Grummer-Strawn L (2004) Pediatric Nutrition Surveillance 2002 Report, Atlanta, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention www.cdc.gov/pedness/pedness-tables/htm/pedness-national-table16.htm
18. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement. CLSI document. M100-S17 [ISBN 1-56238-625-5]. Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898, USA, 2007
19. Kleinbaum DG (1994) Logistic regression. In: Analysis of matched data using logistic regression. A self-learning text. Springer, New York Berlin Heidelberg, pp 227-249
20. JDD Pitout P Nordmann KB Laupland L Poirel 2005 Emergence of Enterobacteriaceae producing extended-spectrum -lactamases (ESBLs) in the community J Antimicrob Agents 56 52 59 10.1093/jac/dki166 1:CAS:528: DC%2BD2MXmsV2itL0%3D (Pubitemid 41418336)
21. J Ena F Arjona C Martinez-Peinado M Lopez-Perezagua C Amador 2006 Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase producing Escherichia coli Urology 68 1169 1174 10.1016/j.urology.2006.08.1075 17169640 (Pubitemid 44895458)
22. TM Coque F Baquero R Canton 2008 Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe Eurosurveillance 13 1 11
23. B Du Y Long H Liu D Chen D Liu Y Xu X Xie 2002 Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae blood stream infection: risk factors and clinical outcome Intensive Care Med 28 1718 1723 10.1007/s00134-002-1521-1 12447513 (Pubitemid 35435472)
24. R Colodner 2005 Extended-spectrum beta-lactamases: a challenge for clinical microbiologists and infection control specialists Am J Infect Control 33 104 107 10.1016/j.ajic.2004.07.010 15761410 (Pubitemid 40283472)
25. N Woodford ME Ward ME Kaufmann J Turton EJ Fagan D James 2004 Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum -lactamases in UK J Antimicrob Chemother 54 735 743 10.1093/jac/dkh424 1:CAS:528:DC%2BD2cXotVyqtrg%3D 15347638 (Pubitemid 39386725)
26. S Yuksel B Ozturk A Kavaz B Ozcakar B Acar H Guriz D Aysev M Ekim F Yalcinkaya 2006 Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections Int J Antimicrob Agents 28 413 416 10.1016/j.ijantimicag.2006.08.009 17000085 (Pubitemid 44636175)
27. M Akram M Shahid AU Khan 2007 Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India Ann Clin Microb 6 4 7 10.1186/1476-0711-6-4 (Pubitemid 46605897)
28. V Gupta A Yadav RM Joshi 2002 Antibiotic resistance pattern in uropathogens Indian J Med Microbiol 20 96 98 1:STN:280:DC%2BD2svjvVKrsw%3D%3D 17657041
29. F Akata M Tatman-Otkun E Özkan O Tansel M Otkun M Tugrul 2003 Prevalence of extended spectrum beta lactamases produced by nosocomial isolates of enterobacteriacae in Trakya University Hospital, Turkey New Microbiol 26 257 262 1:CAS:528:DC%2BD3sXmvFSgu7k%3D 12901421 (Pubitemid 40081737)
30. E YIlmaz H AkalIn S Özbey Y Kordan M SInIrtaş E Gürcüoǧlu C ÖzakIn Y Heper R MIstIk S HelvacI 2008 Risk factors in community-acquired/onset urinary tract infections due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae J Chemother 20 581 585 19028620
31. JR Rodriguez-Bano MD Navarro L Romero L Martinez-Martinez MA Muniain EJ Perea R Perez-Cano A Pascual 2004 Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients J Clin Microbiol 42 1089 1094 10.1128/JCM.42.3. 1089-1094.2004 15004058 (Pubitemid 38332830)